Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nektar Therapeutics (NQ: NKTR )

0.5801 -0.0429 (-6.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,064,771
Open 0.6300
Bid (Size) 0.6000 (35)
Ask (Size) 0.6100 (48)
Prev. Close 0.6230
Today's Range 0.5801 - 0.6520
52wk Range 0.6031 - 5.180
Shares Outstanding 183,801,441
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
 
Via Benzinga
Tempur Sealy International To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Wednesday
Keybanc raised the price target for Tempur Sealy International, Inc. (NYSE: TPX) from $48 to $50. Keybanc analyst Bradley Thomas maintained an Overweight rating. Tempur Sealy International shares rose... 
Via Benzinga

Performance

YTD
-73.51%
-73.51%
1 Month
-25.00%
-25.00%
3 Month
-57.96%
-57.96%
6 Month
-80.07%
-80.07%
1 Year
-83.33%
-83.33%

More News

Read More
Expert Ratings for Nektar Therapeutics
Via Benzinga
Nektar Therapeutics: Q1 Earnings Insights
Via Benzinga
Analyst Ratings for Nektar Therapeutics
Via Benzinga
Nektar Therapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Via Benzinga
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
Via InvestorPlace
Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials
Via Benzinga
Tesla To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Dow Dips 350 Points; S&P 500 Down Over 1%
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher
Via Benzinga
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
Via Benzinga
US Stocks Open Lower; Dow Drops 1%
Via Benzinga
PIXY Stock Alert: What to Know as ShiftPixy Utilizes ChatGPT for Recruiting
Via InvestorPlace
BA Stock Alert: Boeing Halts Deliveries of 787 Dreamliners
Via InvestorPlace
Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?
Via InvestorPlace
Why Nektar Therapeutics Stock Is Plunging Today
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.